03.05.2013
- A once prominent biotechnology investor was handed four years in prison on Thursday after pleading guilty to stock manipulation, the second time he has run afoul of U.S. securities...
30.04.2013
- British scientists are stepping up clinical tests of gene therapy in a bid to help people with advanced heart failure pump blood more efficiently. Researchers said on Tuesday they...
26.04.2013
- New efforts to force labeling of foods made with genetically modified crops, including a bill introduced by U.S. lawmakers Wednesday, have struck a nerve with biotech crop...
25.04.2013
- Biogen reported higher-than-expected first quarter profit on Thursday and raised its full year forecasts, and the U.S. biotechnology said it sees its new drug Tecfidera becoming...
25.04.2013
- In the first quarter 2013, Lonza's business performance was solid and in line with expectations. While the Specialty Ingredients market segment showed a good performance, the...
25.04.2013
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that their new cGMP custom biopharmaceutical manufacturing 'biologics...
25.04.2013
- Laboratory equipment maker Thermo Fisher Scientific, which this month agreed to acquire Life Technologies for more than $13 billion, on Wednesday reported a higher-than-expected...
24.04.2013
- Amgen on Tuesday reported first-quarter sales that fell short of Wall Street expectations for most of its biggest-selling medicines, and its shares fell more than 6%. Revenue for...
24.04.2013
- AquaBounty Technologies expects regulatory approval by the fourth quarter of this year to produce its controversial genetically engineered salmon, its chief executive said on...
22.04.2013
- AstraZeneca is to pay privately held Bind Therapeutics as much as $200 million to develop a cancer medicine using the U.S. biotech company's nanotechnology drug delivery system...
